Skip to main content
Top
Published in: Endocrine 3/2012

Open Access 01-12-2012 | Research Letter

Serum vitamin D levels are decreased and associated with thyroid volume in female patients with newly onset Graves’ disease

Authors: Tetsuyuki Yasuda, Yasuyuki Okamoto, Noboru Hamada, Kazuyuki Miyashita, Mitsuyoshi Takahara, Fumie Sakamoto, Takeshi Miyatsuka, Tetsuhiro Kitamura, Naoto Katakami, Dan Kawamori, Michio Otsuki, Taka-aki Matsuoka, Hideaki Kaneto, Iichiro Shimomura

Published in: Endocrine | Issue 3/2012

Login to get access

Excerpt

It has been shown that vitamin D deficiency is associated with autoimmune diseases, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), inflammatory bowel disease (IBD), multiple sclerosis (MS) and type 1 diabetes (T1DM), and that vitamin D supplementation prevents the onset and/or development of these autoimmune diseases [1]. Furthermore, it was reported more recently that patients with Hashimoto’s thyroiditis, an autoimmune thyroid disease had lower vitamin D levels [2]. However, there are few studies examining vitamin D status in patients with newly onset Graves’ disease. In the present study, we evaluated the vitamin D status in female patients with newly onset GD and the association of serum vitamin D levels with the clinical factors related to GD. …
Literature
1.
go back to reference F. Baeke, T. Takiishi, H. Korf, C. Gysemans, C. Mathieu, Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol. 10(4), 482–496 (2010)PubMedCrossRef F. Baeke, T. Takiishi, H. Korf, C. Gysemans, C. Mathieu, Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol. 10(4), 482–496 (2010)PubMedCrossRef
2.
go back to reference G. Tamer, S. Arik, I. Tamer, D. Coksert, Relative vitamin D insufficiency in Hashimoto’s thyroiditis. Thyroid 21(8), 891–896 (2011)PubMedCrossRef G. Tamer, S. Arik, I. Tamer, D. Coksert, Relative vitamin D insufficiency in Hashimoto’s thyroiditis. Thyroid 21(8), 891–896 (2011)PubMedCrossRef
3.
go back to reference H. Pantazi, P.D. Papapetrou, Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. J. Clin. Endocrinol. Metab. 85(3), 1099–1106 (2000)PubMedCrossRef H. Pantazi, P.D. Papapetrou, Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. J. Clin. Endocrinol. Metab. 85(3), 1099–1106 (2000)PubMedCrossRef
4.
go back to reference N. Vilarrasa, J. Vendrell, J. Maravall, I. Elı′o, E. Solano, P. San Jose′, I. Garcı′a, N. Virgili, J. Soler, J.M. Go′mez, Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine 38(2), 235–242 (2010)PubMedCrossRef N. Vilarrasa, J. Vendrell, J. Maravall, I. Elı′o, E. Solano, P. San Jose′, I. Garcı′a, N. Virgili, J. Soler, J.M. Go′mez, Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine 38(2), 235–242 (2010)PubMedCrossRef
5.
go back to reference A.L. Ponsonby, A. Pezic, J. Ellis, R. Morley, F. Cameron, J. Carlin, T. Dwyer, Variation in associations between allelic variants of the vitamin D receptor gene and onset of type 1 diabetes mellitus by ambient winter ultraviolet radiation levels: a meta-regression analysis. Am. J. Epidemiol. 168(4), 358–365 (2008)PubMedCrossRef A.L. Ponsonby, A. Pezic, J. Ellis, R. Morley, F. Cameron, J. Carlin, T. Dwyer, Variation in associations between allelic variants of the vitamin D receptor gene and onset of type 1 diabetes mellitus by ambient winter ultraviolet radiation levels: a meta-regression analysis. Am. J. Epidemiol. 168(4), 358–365 (2008)PubMedCrossRef
6.
go back to reference J. Smolders, E. Peelen, M. Thewissen, P. Menheere, J.W. Tervaert, R. Hupperts, J. Damoiseaux, The prevalence of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun. Rev. 8(7), 621–626 (2009)PubMedCrossRef J. Smolders, E. Peelen, M. Thewissen, P. Menheere, J.W. Tervaert, R. Hupperts, J. Damoiseaux, The prevalence of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun. Rev. 8(7), 621–626 (2009)PubMedCrossRef
7.
go back to reference N. Naderi, A. Farnood, M. Habibi, F. Derakhshan, H. Balaii, Z. Motahari, M.R. Agah, F. Firouzi, M.G. Rad, R. Aghazadeh, H. Zojaji, M.R. Zali, Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease. J. Gastroenterol. Hepatol. 23(12), 1816–1822 (2008)PubMedCrossRef N. Naderi, A. Farnood, M. Habibi, F. Derakhshan, H. Balaii, Z. Motahari, M.R. Agah, F. Firouzi, M.G. Rad, R. Aghazadeh, H. Zojaji, M.R. Zali, Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease. J. Gastroenterol. Hepatol. 23(12), 1816–1822 (2008)PubMedCrossRef
8.
go back to reference H. Zhou, C. Xu, M. Gu, Vitamin D receptor (VDR) gene polymorphisms and Graves’ disease: a meta-analysis. Clin Endocrinol (Oxf) 70(6), 938–945 (2009)CrossRef H. Zhou, C. Xu, M. Gu, Vitamin D receptor (VDR) gene polymorphisms and Graves’ disease: a meta-analysis. Clin Endocrinol (Oxf) 70(6), 938–945 (2009)CrossRef
9.
go back to reference A. Kurylowicz, E. Ramos-Lopez, T. Bednarczuk, K. Badenhoop, Vitamin D-binding protein (DBP) gene polymorphism is associated with Graves’ disease and the vitamin D status in a Polish population study. Exp. Clin. Endocrinol. Diabetes 114(6), 329–335 (2006)PubMedCrossRef A. Kurylowicz, E. Ramos-Lopez, T. Bednarczuk, K. Badenhoop, Vitamin D-binding protein (DBP) gene polymorphism is associated with Graves’ disease and the vitamin D status in a Polish population study. Exp. Clin. Endocrinol. Diabetes 114(6), 329–335 (2006)PubMedCrossRef
10.
go back to reference A. Misharin, M. Hewison, C.R. Chen, V. Lagishetty, H.A. Aliesky, Y. Mizutori, B. Rapoport, S.M. McLachlan, Vitamin D deficiency modulates Graves’ hyperthyroidism induced in BALB/c mice by thyrotropin receptor immunization. Endocrinology 150(2), 1051–1060 (2009)PubMedCrossRef A. Misharin, M. Hewison, C.R. Chen, V. Lagishetty, H.A. Aliesky, Y. Mizutori, B. Rapoport, S.M. McLachlan, Vitamin D deficiency modulates Graves’ hyperthyroidism induced in BALB/c mice by thyrotropin receptor immunization. Endocrinology 150(2), 1051–1060 (2009)PubMedCrossRef
11.
go back to reference E. Borgogni, E. Sarchielli, M. Sottili, V. Santarlasci, L. Cosmi, S. Gelmini, A. Lombardi, G. Cantini, G. Perigli, M. Luconi, G.B. Vannelli, F. Annunziato, L. Adorini, M. Serio, C. Crescioli, Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells. Endocrinology 149(7), 3626–3634 (2008)PubMedCrossRef E. Borgogni, E. Sarchielli, M. Sottili, V. Santarlasci, L. Cosmi, S. Gelmini, A. Lombardi, G. Cantini, G. Perigli, M. Luconi, G.B. Vannelli, F. Annunziato, L. Adorini, M. Serio, C. Crescioli, Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells. Endocrinology 149(7), 3626–3634 (2008)PubMedCrossRef
12.
go back to reference M. Rotondi, L. Chiovato, The chemokine system as a therapeutic target in autoimmune thyroid diseases: a focus on the interferon-γ inducible chemokines and their receptor. Curr. Pharm. Des. 17(29), 3202–3216 (2011)PubMedCrossRef M. Rotondi, L. Chiovato, The chemokine system as a therapeutic target in autoimmune thyroid diseases: a focus on the interferon-γ inducible chemokines and their receptor. Curr. Pharm. Des. 17(29), 3202–3216 (2011)PubMedCrossRef
Metadata
Title
Serum vitamin D levels are decreased and associated with thyroid volume in female patients with newly onset Graves’ disease
Authors
Tetsuyuki Yasuda
Yasuyuki Okamoto
Noboru Hamada
Kazuyuki Miyashita
Mitsuyoshi Takahara
Fumie Sakamoto
Takeshi Miyatsuka
Tetsuhiro Kitamura
Naoto Katakami
Dan Kawamori
Michio Otsuki
Taka-aki Matsuoka
Hideaki Kaneto
Iichiro Shimomura
Publication date
01-12-2012
Publisher
Springer US
Published in
Endocrine / Issue 3/2012
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-012-9679-y

Other articles of this Issue 3/2012

Endocrine 3/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.